Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy.

Mota TM, Rasmussen TA, Rhodes A, Tennakoon S, Dantanarayana A, Wightman F, Hagenauer M, Roney J, Spelman T, Purcell DF, McMahon J, Hoy JF, Prince HM, Elliott JH, Lewin SR

(2017), AIDS, 31(8), 1137-41

DOI: 10.1097/QAD.0000000000001442

Less frequent CD4 monitoring in virologically suppressed HIV.

McMahon J, Crowe SM

(2017), Lancet HIV, 4(6), e233-4

DOI: 10.1016/S2352-3018(17)30070-X

Post-treatment control in an adult with perinatally acquired HIV following cessation of antiretroviral therapy.

McMahon JH, Chang J, Tennakoon S, Dantanarayana A, Solomon A, Cherry C, Doherty R, Cameron P, Lewin SR

(2017), AIDS, 31(9), 1344-6

DOI: 10.1097/QAD.0000000000001472

Dimeric Fc? receptor enzyme-linked immunosorbent assay to study HIV-specific antibodies: a new look into breadth of Fc? receptor antibodies induced by the RV144 Vaccine Trial.

McLean MR, Madhavi V, Wines BD, Hogarth PM, Chung AW, Kent SJ

(2017), J Immunol, 199(2), 816-26

DOI: 10.4049/jimmunol.1602161

Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance.

McCallum FJ, Persson KM, Fowkes FJ, Reiling L, Mugyenyi CK, Richards JS, Simpson JA, Williams TN, Gilson PR, Hodder AN, Sanders PR, Anders RF, Narum DL, Chitnis C, Crabb BS, Marsh K, Beeson JG

(2017), J Leukoc Biol, 101(4), 913-25

DOI: 10.1189/jlb.5MA0716-294R

HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV.

Madhavi V, Wines BD, Amin J, Emery S; ENCORE1 study group, Lopez E, Kelleher A; Sydney LTNP study group, Center RJ, Hogarth PM, Chung AW, Kent SJ, Stratov I

(2017), J Virol, 91(18), e00700-17

DOI: 10.1128/JVI.00700-17

Effect of combination antiretroviral therapy on HIV-1-specific antibody-dependent cellular cytotoxicity responses in subtype B- and subtype C-infected cohorts.

Madhavi V, Kulkarni A, Shete A, Lee WS, Mclean MR, Kristensen AB, Ghate M, Wines BD, Hogarth PM, Parsons MS, Kelleher A, Cooper DA, Amin J, Emery S, Thakar M, Kent SJ

(2017), J Acquir Immune Defic Syndr, 75(3), 345-53

DOI: 10.1097/QAI.0000000000001380

Anti-HIV-1 ADCC antibodies following latency reversal and treatment interruption.

Lee WS, Kristensen AB, Rasmussen TA, Tolstrup M, ùstergaard L, S?gaard OS, Wines BD, Hogarth PM, Reynaldi A, Davenport MP, Emery S, Amin J, Cooper DA, Kan VL, Fox J, Gruell H, Parsons MS, Kent SJ

(2017), J Virol, 91(15), e00603

DOI: 10.1128/JVI.00603-17

Medication adherence, condom use and sexually transmitted infections in Australian PrEP users: interim results from the Victorian PrEP Demonstration Project.

Lal L, Audsley J, Murphy D, Fairley CK, Stoove M, Roth N, Moore R, Tee BK, Puratmaja N, Anderson PL, Leslie D, Grant RM, De Wit J, Wright E; VicPrEP Study Team

(2017), AIDS, 31(12), 1709-1714

DOI: 10.1097/QAD.0000000000001519

A Phase 1 Human Immunodeficiency Virus vaccine trial for cross-profiling the kinetics of serum and mucosal antibody responses to CN54gp140 modulated by two homologous prime-boost vaccine regimens.

Kratochvil S, McKay PF, Kopycinski JT, Bishop C, Hayes PJ, Muir L, Pinder CL, Cizmeci D, King D, Aldon Y, Wines BD, Hogarth PM, Chung AW, Kent SJ, Held K, Geldmacher C, Dally L, Santos NS, Cole T, Gilmour J, Fidler S, Shattock RJ

(2017), Front Immunol, 8, 595

DOI: 10.3389/fimmu.2017.00595

Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition.

Hearps AC, Tyssen D, Srbinovski D, Bayigga L, Diaz DJD, Aldunate M, Cone RA, Gugasyan R, Anderson DJ, Tachedjian G

(2017), Mucosal Immunol, 10(6), 1480-90

DOI: 10.1038/mi.2017.27

A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial disease.

Halstrom S, Cherry CL, Black M, Thomson R, Goullee H, Baltic S, Allcock R, Temple SE, Price P

(2017), Immunogenetics, 69(5), 287-93

DOI: 10.1007/s00251-017-0972-z

New hepatitis C antiviral treatments eliminate the virus.

Doyle JS, Thompson AJ, Higgs P, Stoove M, Dietze PM, Hellard ME

(2017), Lancet, 390(10092), 358-9

DOI: 10.1016/S0140-6736(17)31817-2

Increased syphilis testing of men who have sex with men: greater detection of asymptomatic early syphilis and relative reduction in secondary syphilis.

Chow EPF, Callander D, Fairley CK, Zhang L, Donovan B, Guy R, Lewis DA, Hellard M, Read P, Ward A, Chen MY; ACCESS collaboration

(2017), Clin Infect Dis, 65(3), 389-95

DOI: 10.1093/cid/cix326

A cross-sectional study of HIV and STIs among male sex workers attending Australian sexual health clinics.

Callander D, Read P, Prestage G, Minichiello V, Chow EP, Lewis DA, McNulty A, Ali H, Hellard M, Guy R, Donovan B

(2017), Sex Transm Infect, 93(4), 299-302

DOI: 10.1136/sextrans-2016-052578

Increased glucose transporter-1 EXPRESSION on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease.

Butterfield TR, Hanna DB, Kaplan RC, Kizer JR, Durkin HG, Young MA, Nowicki MJ, Tien PC, Golub ET, Floris-Moore MA, Titanji K, Fischl MA, Heath SL, Martinson J, Crowe SM, Palmer CS, Landay AL, Anzinger JJ

(2017), AIDS, 31(2), 199-205

DOI: 10.1097/QAD.0000000000001320

Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data.

Boettiger DC, Law MG, Dore GJ, Guy R, Callander D, Donovan B, O'Connor CC, Fairley CK, Hellard M, Matthews G

(2017), BMC Infect Dis, 17(1), 740

DOI: 10.1186/s12879-017-2848-0

Porphyromonas gingivalis antibody levels and diagnosis of coronary artery disease in HIV-positive individuals.

Berquist VL, Hearps AC, Ford P, Jaworowski A, Leishman SJ, Hoy JF, Trevillyan JM

(2017), J Periodontal Res, 52(5), 930-5

DOI: 10.1111/jre.12460

Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults.

Ana-Sosa-Batiz F, Johnston APR, Hogarth PM, Wines BD, Barr I, Wheatley AK, Kent SJ

(2017), Vaccine, 25(47), 6451-8

DOI: 10.1016/j.vaccine.2017.09.062

Anorectal swabs as a marker of male-to-male sexual exposure in STI surveillance systems.

Ampt FH, El Hayek C, Agius PA, Bowring AL, Bartnik N, VAN Gemert C, Fairley CK, Chow EPF, Bradshaw CS, Stephens N, Lim MSC, Hellard ME

(2017), Epidemiol Infect, 145(12), 2530-5

DOI: 10.1017/S095026881700098X

361 362 363 364 365